[{"id":"62fd86f9-af84-448e-80e9-4156070ebb79","acronym":"","url":"https://clinicaltrials.gov/study/NCT04853329","created_at":"2021-04-21T11:53:38.802Z","updated_at":"2024-07-02T16:35:32.261Z","phase":"Phase 1/2","brief_title":"Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma","source_id_and_acronym":"NCT04853329","lead_sponsor":"Conjupro Biotherapeutics, Inc.","biomarkers":" BCL2 • CD20","pipe":" | ","alterations":" CD20 positive","tags":["BCL2 • CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JMT601"],"overall_status":"Suspended","enrollment":" Enrollment 7","initiation":"Initiation: 12/13/2021","start_date":" 12/13/2021","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-10-20"}]